Delivery Order SPE2DB20D2104-SPE2DB23FR97U
Award Date
1/27/23
Potential Completion Date
1/30/23
Potential Value
$8.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,666.91 firm-fixed-price delivery order is for the supply of 4566868388 - Ondansetron HCL 8 mg tablets, with a completion date of January 9, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,914.83 delivery order contract is for the supply of 4,566,188,517 units of 8 mg Ondansetron HCL tablets, with a period of performance ending on October 24, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,151.67 firm fixed-price delivery order covers the supply of 4,566,994,648 units of the drug Ondansetron HCL 4 mg tablets in 30-count packages. The contract has an ultimate completion date of January 22, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,865.48 firm fixed-price delivery order is for the supply of 4 mg ondansetron HCL tablets. The contract has an ultimate completion date of January 27, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the delivery of 4559171567 Ondansetron HCL 8 mg tablets in 30-count packages. The $2,126.26 firm fixed-price delivery order has a completion date of November 23, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,127.94 firm fixed-price delivery order is for the supply of 4564480110 - Ondansetron HCL 8 mg Tablets in 30-count packages. The contract has an ultimate completion date of May 3, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ondansetron HCL 8 mg tablets. The award, valued at $1,108.67, is a firm fixed-price delivery order that does not have a set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $17,160.68, is a delivery order for the supply of 4,566,769,850 units of the drug ondansetron hydrochloride 8 mg tablets. The contract has a firm fixed price and an ultimate completion date of December 20, 2024. This award is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of 8 mg Ondansetron HCL tablets to the Defense Logistics Agency (DLA), a defense agency. The $12,618.04 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, on December 5, 2024, with a completion date of December 6, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of 8 mg Ondansetron hydrochloride tablets to the Defense Logistics Agency (DLA) under a Delivery Order worth $8,518.69. The contract has a Firm Fixed Price pricing type and an ultimate completion date of September 19, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA Troop...